Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of vaccine age restrictions on rotavirus vaccine coverage, Vaccine Safety Datalink 2018-2024.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Rotavirus Vaccine Coverage and Potential Barriers Among US Children Born From 2007 to 2024.

Pediatrics·2026
Same author

Impact of Rotavirus Vaccine on Rotavirus Diarrhea-Associated Hospitalizations among Children under 5 Years of Age in Uganda.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Real-World Effectiveness of Rotavirus Vaccine Against Rotavirus Disease Among Children < 2 Year of Age in Mali.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Effectiveness of monovalent rotavirus vaccine among young children in Pakistan: a test-negative case-control evaluation.

Vaccine·2026
Same author

Clinical, Molecular and Evolutionary Characterization of Noroviruses in Hospitalized Children With Acute Gastroenteritis in Vietnam, 2016 to 2021.

Journal of medical virology·2026

Related Experiment Video

Updated: Oct 25, 2025

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.0K

Global Experience With Rotavirus Vaccines.

Rachel M Burke1, Jacqueline E Tate1, Umesh D Parashar1

  • 1Viral Gastroenteritis Branch, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

The Journal of Infectious Diseases
|August 10, 2021
PubMed
Summary

Rotavirus vaccines significantly reduce severe pediatric diarrhea globally. Ongoing research aims to address geographic disparities in vaccine effectiveness for worldwide optimization.

Keywords:
acute gastroenteritispediatric gastroenteritisrotavirusrotavirus vaccinesvaccine effectivenessvaccine-preventable disease

More Related Videos

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.0K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.5K

Related Experiment Videos

Last Updated: Oct 25, 2025

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.0K
Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.0K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.5K

Area of Science:

  • Pediatrics
  • Vaccinology
  • Infectious Diseases

Background:

  • Rotavirus is a primary cause of severe diarrhea in children globally.
  • Live, oral rotavirus vaccines (Rotarix, RotaTeq) were licensed in 2006, followed by Rotasiil and Rotavac in 2018.
  • The World Health Organization recommended global infant rotavirus vaccination in 2009.

Purpose of the Study:

  • To review the global adoption and effectiveness of rotavirus vaccines.
  • To highlight the expansion of rotavirus vaccine availability and impact.
  • To identify areas for optimizing global vaccine strategies.

Main Methods:

  • Review of vaccine licensure, WHO recommendations, and national introductions.
  • Analysis of demonstrated effectiveness against severe rotavirus disease and mortality.
  • Examination of cross-genotypic protection and benefit-risk profiles.

Main Results:

  • Rotavirus vaccines have been introduced in 106 countries as of March 2021.
  • Vaccines demonstrate effectiveness in preventing severe disease and mortality.
  • Cross-genotypic protection and a favorable benefit-risk profile are confirmed.

Conclusions:

  • Rotavirus vaccination is a critical public health intervention for pediatric diarrhea.
  • Continued research is necessary to understand and mitigate geographic variations in vaccine effectiveness.
  • Optimizing global vaccine strategies is essential for maximizing public health impact.